Johannes Zuber
Auto-generated profile, based on publicly available information

Johannes Zuber

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), 1030 Vienna, Austria

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2011 in Nature
Verified
Journal Article
Closed access
PDF file
JZJohannes Zuber
Johannes Zuber
JSJunwei Shi
Junwei Shi
EWEric Wang
Eric Wang
ARAmy R. Rappaport
Amy R. Rappaport
HHHarald Herrmann
Harald Herrmann
CVChristopher R. Vakoc
Christopher R. Vakoc

20 December 2017 in Nature
Verified
Journal Article
Closed access
PDF file
MMMaja Milanovic
Maja Milanovic
DFDorothy N. Y. Fan
Dorothy N. Y. Fan
DBDimitri Belenki
Dimitri Belenki
JDJ. Henry M. Däbritz
J. Henry M. Däbritz
ZZZhen Zhao
Zhen Zhao
CSClemens A Schmitt
Clemens A Schmitt

7 December 2017 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
GWGordana Wutz
Gordana Wutz
CVCsilla Várnai
Csilla Várnai
KNKota Nagasaka
Kota Nagasaka
DCDavid A Cisneros
David A Cisneros
RSRoman R Stocsits
Roman R Stocsits
JPJan‐Michael Peters
Jan‐Michael Peters
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

16 January 2019 in Nature
Verified
Journal Article
Closed access
PDF file
RWReiner A. Wimmer
Reiner A. Wimmer
ALAlexandra Leopoldi
Alexandra Leopoldi
MAMartin Aichinger
Martin Aichinger
NWNikolaus Wick
Nikolaus Wick
BHBrigitte Hantusch
Brigitte Hantusch
JPJosef M Penninger
Josef M Penninger

1 December 2013 in Cell Reports
Verified
Journal Article
Open access
CFChristof Fellmann
Christof Fellmann
THThomas Hoffmann
Thomas Hoffmann
VSVaishali Sridhar
Vaishali Sridhar
BHBarbara Hopfgartner
Barbara Hopfgartner
MMMatthias Muhar
Matthias Muhar
JZJohannes Zuber
Johannes Zuber
Short hairpin RNA (shRNA) technology enables stable and regulated gene repression. For establishing experimentally versatile RNAi tools and minimizing toxicities, synthetic shRNAs can be embedded into endogenous microRNA contexts. However, due to our incomplete understanding of microRNA biogenesis, such "shRNAmirs" often fail to trigger potent knockdown, especially when expressed from a single genomic copy. Following recent advances in design of synthetic shRNAmir stems, here we take a systematic approach to optimize the experimental miR-30 backbone. Among several favorable features, we identify a conserved element 3' of the basal stem as critically required for optimal shRNAmir processing and implement it in an optimized backbone termed "miR-E", which strongly increases mature shRNA levels and knockdown efficacy. Existing miR-30 reagents can be easily converted to miR-E, and its combination with up-to-date design rules establishes a validated and accessible platform for generating effective single-copy shRNA libraries that will facilitate the functional annotation of the genome.

6 August 2015 in Nature Medicine
Verified
Journal Article
Open access
PDF file
AAAsh A Alizadeh
Ash A Alizadeh
VAVictoria Aranda
Victoria Aranda
ABAlberto Bardelli
Alberto Bardelli
CBCedric Blanpain
Cedric Blanpain
CBChristoph Bock
Christoph Bock
JZJessica Zucman-rossi
Jessica Zucman-rossi
In this Perspective, attendees of the Herrenhausen Tumour Heterogeneity meeting discuss the challenges in understanding tumour heterogeneity and propose ways forward for overcoming these hurdles. The extent of tumor heterogeneity is an emerging theme that researchers are only beginning to understand. How genetic and epigenetic heterogeneity affects tumor evolution and clinical progression is unknown. The precise nature of the environmental factors that influence this heterogeneity is also yet to be characterized. Nature Medicine, Nature Biotechnology and the Volkswagen Foundation organized a meeting focused on identifying the obstacles that need to be overcome to advance translational research in and tumor heterogeneity. Once these key questions were established, the attendees devised potential solutions. Their ideas are presented here.